Literature DB >> 6489330

Susceptibility of Legionella spp. to quinolone derivatives and related organic acids.

G Ruckdeschel, W Ehret, A Ahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6489330     DOI： 10.1007/bf01977502

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Activities of newer quinolones against Legionella group organisms.

Authors:  D Greenwood; A Laverick
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

2.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

3.  Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila.

Authors:  M F Miller; J R Martin; P Johnson; J T Ulrich; E J Rdzok; P Billing
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

4.  Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors:  H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.

Authors:  A Bauernfeind; C Petermüller
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267
  5 in total
  12 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

2.  Penetration of ciprofloxacin into bronchial secretions.

Authors:  E Bergogne-Bérézin; G Berthelot; P Even; M Stern; P Reynaud
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

3.  Intraphagocytic activity of ciprofloxacin and CI 934.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

4.  Determination of norfloxacin and ciprofloxacin concentrations in serum and urine by high-pressure liquid chromatography.

Authors:  S J Morton; V H Shull; J D Dick
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

5.  Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.

Authors:  A Chin; M P Okamoto; M A Gill; D A Sclar; T V Berne; A E Yellin; P N Heseltine; M D Appleman
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 6.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Penetration of enoxacin into bronchial secretions.

Authors:  I W Fong; A Vandenbroucke; M Simbul
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.

Authors:  J L Whiting; N Cheng; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

9.  [Respiratory tract infections--clinical results with ofloxacin].

Authors:  P M Shah; H Knothe
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 10.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.